WallStreetZenWallStreetZen

NASDAQ: ABVC
Abvc Biopharma Inc Stock Ownership - Who owns Abvc Biopharma?

Insider buying vs selling

Have Abvc Biopharma Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ABVC insiders and whales buy or sell their stock.

ABVC Shareholders

What type of owners hold Abvc Biopharma Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Tsung Shann Jiang114.62%12,103,971$17.19MInsider
Shuling Jiang74.89%7,908,805$11.23MInsider
Eugene Jiang6.94%732,716$1.04MInsider
Yoshinobu Odaira1.55%163,702$232.46kInsider
Shinyu Miao0.64%67,378$95.68kInsider
Renaissance Technologies LLC0.34%36,100$51.26kInstitution
Vanguard Group Inc0.26%27,247$38.69kInstitution
Citadel Advisors LLC0.26%27,158$38.56kInstitution
Geode Capital Management LLC0.18%19,480$27.66kInstitution
Howard Doong0.17%18,404$26.13kInsider

1 of 2

ABVC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ABVC0.52%99.48%
IMRN0.00%0.00%
CDIO7.67%34.34%Net BuyingNet Buying
VAXX4.14%95.86%Net Selling
NRBO0.25%99.75%

Abvc Biopharma Stock Ownership FAQ

Who owns Abvc Biopharma?

Abvc Biopharma (NASDAQ: ABVC) is owned by 1.05% institutional shareholders, 199.11% Abvc Biopharma insiders, and 0.00% retail investors. Tsung Shann Jiang is the largest individual Abvc Biopharma shareholder, owning 12.10M shares representing 114.62% of the company. Tsung Shann Jiang's Abvc Biopharma shares are currently valued at $17.19M.

If you're new to stock investing, here's how to buy Abvc Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.